Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. What is it? GET STARTED Worms and genetic theft: what drives the scientist behind the new RNAi drug WORCESTER, Mass. — In his Nobel Prize lecture in 2006, Craig Mello played a clip from a horror movie of sorts, starring a tiny worm. Filmed through a microscope, the worm wiggled toward a mysterious black ring and ominously slid through it.“Watch this,” Mello said, pointing toward the screen. Suddenly, the ring snapped shut around the worm’s tail. The ring, Mello explained, is a lasso thrown by a fungus, readying to catch and devour its prey. Log In | Learn More Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED University of Massachusetts Medical School biologist and Nobel Prize winner Craig Mello Pat Greenhouse/The Boston Globe By Orly Nadell Farber Aug. 28, 2018 Reprints Tags biotechnologydrug developmentgeneticsSTAT+ In the Lab STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. What’s included?